For most of the past year, Markel told a tidy story: the insurance engine that had sputtered was finally running clean, and the company was using the cash to shrink its share count. Then a collateral shortfall at State National, its fronting business, went from a footnote in the first quarter to the dominant topic of the second-quarter call. When Markel reports third-quarter results after the close on October 28, the question is less whether the underwriting turnaround continues than whether management can draw a firm boundary around a problem that, so far, has only grown.
The Street is not asking for much on the headline numbers. Consensus calls for earnings of $30.09 per share, about 2.6% below the $30.90 earned a year ago, on revenue of roughly $4.01 billion, up a modest 1.9%. That is essentially a flat quarter, and it compares with second-quarter earnings of $19.51 per share. Markel's reported earnings swing with investment marks on its large equity portfolio, so the per-share figure is a noisy gauge of operating health. Management has offered no formal outlook to anchor these estimates, which places more weight on segment detail and disclosure quality than on a simple beat or miss.
State National is the swing factor. In the first quarter, management described a current collateral shortfall against a capacity provider, engaged an outside actuarial review, and called the issue immaterial. By the second quarter, executives acknowledged that collateral had been topped up or increased for similar lines with other reinsurers, which suggests the issue is broadening rather than being contained. They also stressed that State National is well capitalized, has generated more than $1 billion of cumulative earnings since its $900 million acquisition in 2017, and would receive parent support if needed. What would validate that reassurance is a quantified figure, a completed actuarial review, and evidence that no additional counterparties have required more collateral. A charge or reserve strengthening that is sized and finished could even clear the air. An open-ended disclosure, or signs that capacity providers are walking away, would challenge the narrative much more seriously.
The core insurance trends deserve equal attention, because they are what justify owning the stock. The Markel Insurance combined ratio improved from 97% in the third quarter of 2025 to about 92.8% by the first quarter of 2026, with the continuing divisions near 91%. Keeping that figure in the low 90s against a year-ago quarter that ran 97% would show the turnaround is real. The backdrop is getting harder, though. US property rates are falling 10% to 20%, casualty rate increases are slowing toward the pace of loss trend, and new MGAs and sidecars are competing aggressively. Favorable prior-year reserve development has also shrunk, from 7 points to 5 points year over year, so any further decline would mean less cushion behind reported margins. International growth and adjusted premium growth in the high single digits, excluding the Global Re exit and the Hagerty shift, are the clearest signs that underwriting discipline is not costing volume. On the Markel Ventures side, Industrial earnings have been falling on weak transportation demand, and any stabilization there would help offset softer insurance pricing. Operating cash flow, which collapsed to $16 million in the first quarter, needs to recover as well.
The market has already passed judgment. Shares are down 4.4% since the last report, trailing the S&P 500 by about 9.5 percentage points, and sit near $1,872, below the 200-day average of roughly $1,908 and in the middle of the post-earnings range. Sentiment has turned more bearish, moving from 52.3% to 58.2%. That lowers the bar somewhat. It also means buybacks, which management said could retire the next 10% of shares in under five years, can do more work at these prices.
Ultimately, this report turns on containment. If Markel can put a number and an endpoint on State National while holding its combined ratio near recent levels, the turnaround story remains intact. If the collateral issue is still unquantified and widening, steady underwriting results may not be enough to win back investors.